Thomas Trimarchi, President and CFO at BridgeBio Pharma, Inc. (BBIO), sold 56,023 shares at $50.14 ($2.8M) on 2025-08-18, disclosed to the SEC on 2025-08-19.
Scheduled sale ($2.8M) by President and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.32 | 21,317 | $1.1M | 38.6% |
| 2 | $50.14 | 15,380 | $771K | 27.2% |
| 3 | $50.14 | 15,380 | $771K | 27.2% |
| 4 | $50.94 | 1,973 | $101K | 3.5% |
| 5 | $50.94 | 1,973 | $101K | 3.5% |
| Total | $50.65 avg | 56,023 |
| $2.8M |
| 100% |
| Filing → |
| BBIO | SELL | 2025-11-18 | $2.3M | — | Filing → |
| BBIO | SELL | 2025-08-22 | $4.2M | — | Filing → |